About LTS Lohmann
LTS Lohmann is a Healthcare company based in Caldwell (United States) founded in 1997, and was acquired by Dievini in July 2014. Drug delivery systems targeting multiple disease indications are developed. LTS Lohmann has completed 3 acquisitions, including Eitan Medical, RenPharm and Tapemark. Its website ltslohmann.com draws about 10 thousand monthly visits. Its focus areas include Life Sciences, Drug Delivery and Diversified. Its legal entity is LTS LOHMANN THERAPY SYSTEMS CORP. Its competitors include PharmaJet, Suono Bio and Renovis; 3 of its 3 listed competitors have raised funding.
Company details
LTS Lohmann was founded in 1997 in Caldwell, United States. Operations center on the pharmaceutical sector, where oral, transdermal, and intradermal drug delivery systems are developed. Technologies such as microarray patches and oral thin films are produced for industry use. Applications include the delivery of vaccines and therapies for opioid use disorder, pain management, and nausea or vomiting.
- Headquarters Caldwell, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ltslohmann.com/en
- Social LinkedIn YouTube
- Acquired by Dievini (Jul 2014)
- Legal Name Lts Lohmann Therapy Systems Corp.
- Latest Funding Round$1.2M (USD), Grant
Dec 2023
- InvestorsGates Foundation
& 1 more
- Investments & AcquisitionsEitan Medical
& 2 more
- Acquired byDievini
(Jul 2014)
Apps and channels of LTS Lohmann
its YouTube channel LTS Lohmann Therapie-Systeme AG (EN) has 1.2K subscribers and 30 videos.
Videos from LTS Lohmann
The most watched videos on LTS Lohmann's YouTube channel, LTS Lohmann Therapie-Systeme AG (EN) (1.2K subscribers). Click a video to play it here.
More on LTS Lohmann Therapie-Systeme AG (EN).
Funding Insights of LTS Lohmann
- Total Rounds 1
- Last Round Grant — $1.2M
- First Round $1.2M
(Dec 2023)
- Investors Count 1
All 1 funding rounds of LTS Lohmann with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2023 | $1.2M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in LTS Lohmann
LTS Lohmann has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation and dievini.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in life and health sciences companies. | dievini.de | Germany | ||
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States |
Investor details for LTS Lohmann
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LTS Lohmann
37 people are tracked at LTS Lohmann (18 in leadership, 19 in team).
| Name | Role | Group |
|---|---|---|
Ulrich Sielaff | Chief Legal & HR Officer | Leadership |
Ori Ben David | VP R&d | Leadership |
Marius Bauer | Head Of Laboratory (research And Development) | Leadership |
Bas van Buijtenen | Chief Executive Officer | Leadership |
Alejandro Sandoval | Director, Business Development | Leadership |
Stefan Arnold | Director Business Development Asia - Head Asia Office At LTS - Lohmann Therapie Systeme AG | Leadership |
Patrick Mohr | Corporate Vice President R&d, Head Of Pharmaceutical Development | Leadership |
Benjamin Schinor | Director - Head Of Laboratory | Leadership |
May de Las Alas -Pidding | Director, MAP (micro Array Patch) Product Management | Leadership |
Michael Linn | Director / Head Of Laboratory | Leadership |
B. Michael Hoffmann | Chief Operating Officer | Leadership |
Christian Langer | Corporate Senior Vice President Global Quality | Leadership |
Andrei Yosef | President And General Manager LTS Device Technologies | Leadership |
Thomas Maichle | Corporate Vice President Sales & Business Development Eu/ AP | Leadership |
Claudia Schaefer | COO / Mitglied Des Vorstandes | Leadership |
Dr. Stefan Lorscheidt | Chief Of Staff | Leadership |
Julia Lodder-Gadaczek | Head Of Analytical Development II | Leadership |
H. Werner Lüscher | Chief Financial Officer | Leadership |
Sebastiaan M. Van Buijtenen | Chairman | Team |
Ekaterina Churbanova | R&d Lab Technician | Team |
17 more people are available in the full profile.
Complete people profiles for LTS Lohmann
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LTS Lohmann
LTS Lohmann has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Eitan Medical, RenPharm and Tapemark.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Sterile and environmentally controlled pharmaceutical products are developed and manufactured. | renpharm.com | Newton, United States | 2016 | Oct 2025 | •••• | |
Developer of smart wearable devices for drug delivery | eitanmedical.com | Netanya, Israel | 2015 | Apr 2023 | •••• | |
CDMO with expertise in transdermal patches and oral transmucosal thin films and catering to pharmaceutical and medical device markets | tapemark.com | Saint Paul, United States | 1952 | Aug 2022 | •••• |
Complete acquisition details for LTS Lohmann
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of LTS Lohmann
6 dated milestones of LTS Lohmann across 28 years, from founding to its latest funding, stage changes and deals.
- Founded LTS Lohmann is founded.
- Exit Acquired by Dievini.
- Acquisition Acquires Tapemark.
- Acquisition Acquires Eitan Medical.
- Funding First funding round of $1.2M.
- Acquisition Acquires RenPharm.
Competitors of LTS Lohmann
LTS Lohmann has 3 listed competitors in our database, 3 of them funded. They include PharmaJet, Suono Bio and Renovis.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pharmajet.com | 2005 | Golden, United States | $59.4M | 15 | Provider of needle-free injection technology | |
| suonobio.com | 2015 | Cambridge, United States | $12.68M | Developer of technology to enable ultra-rapid delivery of therapeutics to the gastrointestinal tract | ||
| renovis.com | 2000 | San Francisco, United States | $45M | 368 | Drugs for neurological diseases are discovered and developed. |
Detailed competitors of LTS Lohmann
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of LTS Lohmann
The website of LTS Lohmann (ltslohmann.com) receives about 10.2K visits a month.
- Monthly visits10.2K
▲ 16.7% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as LTS Lohmann (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lts Lohmann
Complete news archive for LTS Lohmann
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LTS Lohmann
LTS Lohmann was founded in 1997 and raised its 1st funding round 26 years after it was founded.
LTS Lohmann is headquartered in Caldwell, United States. It is registered at Caldwell, Idaho, United States.
LTS Lohmann was founded in 1997 in Caldwell, United States. Operations center on the pharmaceutical sector, where oral, transdermal, and intradermal drug delivery systems are developed. Technologies such as microarray patches and oral thin films are produced for industry use. Applications include the delivery of vaccines and therapies for opioid use disorder, pain management, and nausea or vomiting.
LTS Lohmann has made 3 acquisitions, including Eitan Medical, RenPharm, and Tapemark.
LTS Lohmann has 2 investors. Key investors include Gates Foundation, and dievini.
LTS Lohmann operates through Lts Lohmann Therapy Systems Corp..
Yes. LTS Lohmann was acquired by Dievini in July 2014.